Astragalus Polysaccharides and Metformin May Have Synergistic Effects on the Apoptosis and Ferroptosis of Lung Adenocarcinoma A549 Cells

I. Yun Lee, Ting Chung Wang, Yu Jen Kuo, Wei Tai Shih, Pei Rung Yang, Cheng Ming Hsu, Yu Shih Lin, Ren Shyang Kuo, Ching Yuan Wu*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

1 Scopus citations

Abstract

Astragalus polysaccharides (APSs), the compounds extracted from the common herb Astragalus membranaceus, have been extensively studied for their antitumor properties. In this study, we investigated the effect of APS on lung adenocarcinoma A549 cells. The effects of APS and the anti-diabetic drug metformin on apoptosis and ferroptosis were compared. Furthermore, the combination treatment of APS and metformin was also investigated. We found that APS not only reduced the growth of lung cancer cells but also had a synergistic effect with metformin on A549 cells. The study results showed that it may be promising to use APS and metformin as a combination therapy for the treatment of lung adenocarcinoma.

Original languageEnglish
Pages (from-to)7782-7794
Number of pages13
JournalCurrent Issues in Molecular Biology
Volume46
Issue number8
DOIs
StatePublished - 23 07 2024

Bibliographical note

Publisher Copyright:
© 2024 by the authors.

Keywords

  • A549 cells
  • Astragalus polysaccharides (APS)
  • apoptosis
  • ferroptosis
  • lung cancer
  • metformin

Fingerprint

Dive into the research topics of 'Astragalus Polysaccharides and Metformin May Have Synergistic Effects on the Apoptosis and Ferroptosis of Lung Adenocarcinoma A549 Cells'. Together they form a unique fingerprint.

Cite this